BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.48B |
| 2 |
Microsoft
MSFT
|
+$1.33B |
| 3 |
Meta Platforms (Facebook)
META
|
+$476M |
| 4 |
ExxonMobil
XOM
|
+$467M |
| 5 |
Tesla
TSLA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$248M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$236M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$199M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$179M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.11% |
| 2 | Healthcare | 7.76% |
| 3 | Financials | 6.89% |
| 4 | Consumer Discretionary | 6.36% |
| 5 | Communication Services | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Chemours
CC
$2.3B
| $377K | ﹤0.01% |
14,340
+4,965
| +53% | +$141K |
|
|
LBAI
2877
DELISTED
Lakeland Bancorp Inc
LBAI
| $375K | ﹤0.01% |
31,031
+15,376
| +98% | +$197K |
|
|
AXON
2878
PUT
Axon Enterprise
AXON
$50B
| $375K | ﹤0.01% |
+12
| New | +$3.33K |
|
|
HAYN
2879
DELISTED
Haynes International, Inc.
HAYN
| $375K | ﹤0.01% |
6,233
+2,504
| +67% | +$144K |
|
2880
Rigel Pharmaceuticals
RIGL
$762M
| $374K | ﹤0.01% |
25,296
+4,923
| +24% | +$66.3K |
|
2881
AnaptysBio
ANAB
$1.66B
| $372K | ﹤0.01% |
16,520
-4,433
| -21% | -$105K |
|
2882
Horizon Bancorp
HBNC
$1.05B
| $372K | ﹤0.01% |
28,977
+5,496
| +23% | +$70.1K |
|
2883
Elanco Animal Health
ELAN
$11.2B
| $371K | ﹤0.01% |
22,810
-159,948
| -88% | -$2.5M |
|
2884
PUT
Eastman Chemical
EMN
$8.43B
| $371K | ﹤0.01% |
+37
| New | +$3.25K |
|
2885
Ranger Energy Services
RNGR
$405M
| $371K | ﹤0.01% |
32,833
-18,691
| -36% | -$195K |
|
|
AHRT
2886
AH Realty Trust
AHRT
$506M
| $370K | ﹤0.01% |
35,590
+4,639
| +15% | +$52.6K |
|
2887
CALL
Wyndham Hotels & Resorts
WH
$5.51B
| $368K | ﹤0.01% |
48
-12
| -20% | -$942 |
|
2888
First Hawaiian
FHB
$3.39B
| $368K | ﹤0.01% |
16,768
-24,486
| -59% | -$526K |
|
|
ZYXI
2889
DELISTED
Zynex
ZYXI
| $367K | ﹤0.01% |
29,636
-4,613
| -13% | -$55.3K |
|
2890
Savara
SVRA
$1.08B
| $366K | ﹤0.01% |
73,494
+35,269
| +92% | +$170K |
|
2891
CALL
Advance Auto Parts
AAP
$3.46B
| $366K | ﹤0.01% |
43
-65
| -60% | -$4.49K |
|
|
OSG
2892
Octave Specialty Group
OSG
$212M
| $365K | ﹤0.01% |
23,370
+8,318
| +55% | +$131K |
|
2893
Fennec Pharmaceuticals
FENC
$423M
| $364K | ﹤0.01% |
32,769
+13,223
| +68% | +$133K |
|
2894
Fulgent Genetics
FLGT
$513M
| $364K | ﹤0.01% |
16,779
+5,043
| +43% | +$125K |
|
2895
Under Armour Class C
UA
$2.25B
| $363K | ﹤0.01% |
50,889
+37,593
| +283% | +$288K |
|
|
LENZ
2896
LENZ Therapeutics
LENZ
$145M
| $362K | ﹤0.01% |
+16,221
| New | +$337K |
|
2897
OrthoPediatrics
KIDS
$653M
| $362K | ﹤0.01% |
12,414
+5,707
| +85% | +$160K |
|
|
MRSN
2898
DELISTED
Mersana Therapeutics
MRSN
| $362K | ﹤0.01% |
3,229
+1,529
| +90% | +$152K |
|
|
EPIX
2899
DELISTED
ESSA Pharma
EPIX
| $361K | ﹤0.01% |
42,495
-14,971
| -26% | -$131K |
|
|
SPWR
2900
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $360K | ﹤0.01% |
1,200
+1,050
| +700% | +$3.46K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2024 Portfolio in Review
As of Q1 2024, BNP Paribas Financial Markets held 4,321 positions worth $114B, up 29% from $88.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $19.4B of net new capital in Q1 2024, opening 290 new positions and adding to 2,190 existing holdings. Its largest new stake was Bunge Global: 261,576 shares worth $26.8M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Amazon, an estimated $248M trimmed.
- BNP Paribas Financial Markets's largest Q1 2024 buy was Bunge Global: 261,576 shares worth $26.8M.
- BNP Paribas Financial Markets added most to Apple in Q1 2024, an estimated $1.48B increase.
- BNP Paribas Financial Markets's biggest Q1 2024 reduction was Amazon, cutting an estimated $248M.
- BNP Paribas Financial Markets fully exited Direxion Daily S&P 500 Bull 2X ETF in Q1 2024, selling an estimated $36.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $114B portfolio in Q1 2024.
- BNP Paribas Financial Markets opened 290 new positions and closed 292 in Q1 2024.
- BNP Paribas Financial Markets's portfolio value rose 29% quarter-over-quarter to $114B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2024, filed 1 May 2024.